[HTML][HTML] Targeting endogenous DLK1 exerts antitumor effect on hepatocellular carcinoma through initiating cell differentiation
CM Cai, X Xiao, BH Wu, BF Wei, ZG Han - Oncotarget, 2016 - ncbi.nlm.nih.gov
Cancer stem cells (CSCs) are responsible for tumor initiation and progression. We
previously showed that Delta-like homolog 1 (DLK1) may be a therapeutic target against the …
previously showed that Delta-like homolog 1 (DLK1) may be a therapeutic target against the …
DLK1 as a potential target against cancer stem/progenitor cells of hepatocellular carcinoma
Abstract Delta-like 1 homolog (DLK1; Drosophila) is a hepatic stem/progenitor cell marker in
fetal livers that plays a vital role in oncogenesis of hepatocellular carcinoma (HCC). The aim …
fetal livers that plays a vital role in oncogenesis of hepatocellular carcinoma (HCC). The aim …
Delta‐like 1 contributes to cell growth by increasing the interferon‐inducible protein 16 expression in hepatocellular carcinoma
F Yu, X Hao, H Zhao, C Ge, M Yao, S Yang… - Liver …, 2010 - Wiley Online Library
Abstract Background: Delta‐like 1 (DLK1), a fetal liver stem cell marker, is strongly
expressed in human and rodent fetal liver, but not in adult liver. Notably, dysregulation of …
expressed in human and rodent fetal liver, but not in adult liver. Notably, dysregulation of …
DDX17 promotes hepatocellular carcinoma progression via inhibiting Klf4 transcriptional activity
Y Xue, X Jia, C Li, K Zhang, L Li, J Wu, J Yuan… - Cell death & …, 2019 - nature.com
Abstract DEAD box RNA helicase 17 (DDX17) is a transcriptional regulator of several
transcription factors, which is more appreciated than its role in RNA metabolism. However …
transcription factors, which is more appreciated than its role in RNA metabolism. However …
KLF4-mediated upregulation of CD9 and CD81 suppresses hepatocellular carcinoma development via JNK signaling
Y Li, S Yu, L Li, J Chen, M Quan, Q Li, Y Gao - Cell death & disease, 2020 - nature.com
Tetraspanins CD9 and CD81 frequently serve as the surface markers of exosomes, which
are involved in intercellular communication during tumor progression. KLF4 is a well-known …
are involved in intercellular communication during tumor progression. KLF4 is a well-known …
[HTML][HTML] Plasma DCLK1 is a marker of hepatocellular carcinoma (HCC): Targeting DCLK1 prevents HCC tumor xenograft growth via a microRNA-dependent …
Tumor stem cell marker Doublecortin-like kinase1 (DCLK1) is upregulated in several solid
tumors. The role of DCLK1 in hepatocellular carcinoma (HCC) is unclear. We …
tumors. The role of DCLK1 in hepatocellular carcinoma (HCC) is unclear. We …
RETRACTED ARTICLE: Up-regulation of CDK16 by multiple mechanisms in hepatocellular carcinoma promotes tumor progression
Y Wang, X Qin, T Guo, P Liu, P Wu, Z Liu - Journal of experimental & …, 2017 - Springer
Background Hepatocellular carcinoma (HCC) remains difficult to cure due to lack of effective
treatment and the molecular mechanisms are complex and not completely understood. In …
treatment and the molecular mechanisms are complex and not completely understood. In …
DCLK1 is Overexpressed and Associated with Immune Cell Infiltration in Hepatocellular Carcinoma
JM Velázquez-Enríquez, R Cerna… - Biochemical …, 2024 - Springer
Recent research has shown that Doublecortin-like kinase 1 (DCLK1) is overexpressed in
different types of cancer. It has recently been described as a cancer stem cells (CSCs) …
different types of cancer. It has recently been described as a cancer stem cells (CSCs) …
Serum DLK1 is a potential prognostic biomarker in patients with hepatocellular carcinoma
H Li, M Cui, T Chen, H Xie, Y Cui, H Tu, F Chen, C Ge… - Tumor Biology, 2015 - Springer
Hepatocellular carcinoma (HCC) is the sixth most prevalent cancer and the third most
frequent cause of cancer-related death in developing countries, especially in East Asia and …
frequent cause of cancer-related death in developing countries, especially in East Asia and …
[HTML][HTML] Clinical role and biological function of CDK5 in hepatocellular carcinoma: A study based on immunohistochemistry, RNA-seq and in vitro investigation
R Zhang, P Lin, H Yang, Y He, YW Dang, ZB Feng… - Oncotarget, 2017 - ncbi.nlm.nih.gov
To investigate the clinical role and biological function of cyclin-dependent kinase 5 (CDK5)
in hepatocellular carcinoma (HCC), 412 surgically resected tissue samples (HCC, n= 171; …
in hepatocellular carcinoma (HCC), 412 surgically resected tissue samples (HCC, n= 171; …
相关搜索
- antitumor effect cell differentiation
- antitumor effect hepatocellular carcinoma
- hepatocellular carcinoma cell differentiation
- hepatocellular carcinoma tumor progression
- hepatocellular carcinoma targeting dclk1
- hepatocellular carcinoma rna seq
- hepatocellular carcinoma interferon inducible
- hepatocellular carcinoma biological function
- hepatocellular carcinoma up regulation
- hepatocellular carcinoma cell growth
- hepatocellular carcinoma cell infiltration